Clinuvel PharmaceuticalsCUV 
$9.82-0.67%24h
-0.67%24h
Global rank11480
Market cap$485.22M
Change 7d-5.64%
YTD Performance-8.06%
SP500 benchmarkUnderperform
P/E16.62
P/S9.29
Revenue$52.25M
Earnings$20.42M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Clinuvel Pharmaceuticals (CUV)
Clinuvel Pharmaceuticals has an EPS of $0.591. In 2022, the company made an earnings per share (EPS) of $0.403. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for CUV
-
Value:-
EPS history for Clinuvel Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $0.591 | 46.65% |
| 2022 | $0.403 | -16.74% |
| 2021 | $0.484 | 46.67% |
| 2020 | $0.33 | - |
View the highest EPS stocks
